Institutional investors hold a majority ownership of TECH through the 98.11% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2017, these large investors purchased a net $241.1 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TIMESSQUARE CAPITAL MANAGEMENT L... Bought 348.0 Thousand shares of Bio-Techne Corp
EPOCH INVESTMENT PARTNERS, INC. Bought 280.4 Thousand shares of Bio-Techne Corp